{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:53:20Z","timestamp":1781654000797,"version":"3.54.5"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>C-Myc overexpression is an important molecular hallmark of pancreatic ductal adenocarcinoma (PDAC), but directly targeting c-Myc is extremely challenging. Identifying key upstream factors involved in c-Myc overexpression provides promising indirect targets for c-Myc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Public transcriptomic and clinical datasets, including TCGA, GEO, were integrated to identify c-Myc-associated long noncoding RNAs in PDAC, with\n                      <jats:italic>LINC01963<\/jats:italic>\n                      selected for further investigation. The functional roles of\n                      <jats:italic>LINC01963<\/jats:italic>\n                      were validated using human PDAC cell lines and in vivo proliferation models. The molecular mechanisms underlying c-Myc regulation by\n                      <jats:italic>LINC01963<\/jats:italic>\n                      were explored using RNA pull-down, RIP-seq, RIP-qPCR, Co-IP, mass spectrometry, ubiquitination assays, truncation and site-directed mutagenesis analyses, and dual-luciferase reporter assays. Survival associations were evaluated using Kaplan\u2013Meier analysis and Cox proportional hazards regression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Here, the long noncoding RNAs (lncRNAs) highly expressed in PDAC and significantly correlated with\n                      <jats:italic>c-Myc<\/jats:italic>\n                      expression were identified using RNA sequencing datasets. Among them,\n                      <jats:italic>LINC01963<\/jats:italic>\n                      was found to interact with c-Myc, as confirmed by RNA pull-down and RIP-qPCR assays. Furthermore, high\n                      <jats:italic>LINC01963<\/jats:italic>\n                      expression was correlated with poor PDAC prognosis, and functional studies demonstrated that its knockdown inhibited PDAC cell proliferation and xenograft tumor growth. Mechanistic studies identified\n                      <jats:italic>LINC01963<\/jats:italic>\n                      as a key regulator of\n                      <jats:italic>c-Myc<\/jats:italic>\n                      stability, consequently affecting cell cycle through the c-Myc\/p21-related signaling pathways. Further investigation revealed that\n                      <jats:italic>LINC01963<\/jats:italic>\n                      enhanced N6-methyladenosine (m\u2076A) modification of\n                      <jats:italic>c-Myc<\/jats:italic>\n                      mRNA by protecting methyltransferase-like 3 (METTL3) protein from KDM1B-mediated K48-linked ubiquitination and proteasomal degradation. Intriguingly,\n                      <jats:italic>LINC01963<\/jats:italic>\n                      also stabilized\n                      <jats:italic>c-Myc<\/jats:italic>\n                      mRNA by facilitating the formation of a ternary complex with insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) and m\u2076A-modified\n                      <jats:italic>c-Myc<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our study reveals that\n                      <jats:italic>LINC01963<\/jats:italic>\n                      promotes PDAC tumorigenesis through METTL3\/IGF2BP2 axis-coordinated regulation of c-Myc, suggesting a new strategy for indirectly targeting c-Myc.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-026-03650-5","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:47:23Z","timestamp":1770194843000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["LINC01963 promotes pancreatic ductal adenocarcinoma proliferation via METTL3\/IGF2BP2 axis-mediated m\u2076A modification of c-Myc"],"prefix":"10.1186","volume":"45","author":[{"given":"Qixian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuqing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sichong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoding","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamei","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"3650_CR1","first-page":"1729","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA. Pasca di Magliano M, Maitra A. Pancreatic cancer: Advances and challenges Cell. 2023;186:1729\u201354.","journal-title":"Pancreatic cancer: Advances and challenges Cell"},{"key":"3650_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3650_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.canlet.2014.01.004","volume":"346","author":"J Long","year":"2014","unstructured":"Long J, Luo G, Xiao Z, Liu Z, Guo M, Liu L, et al. Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, China. Cancer Lett. 2014;346:273\u20137.","journal-title":"Cancer Lett"},{"key":"3650_CR4","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1172\/JCI73455","volume":"124","author":"EJ Koay","year":"2014","unstructured":"Koay EJ, Truty MJ, Cristini V, Thomas RM, Chen R, Chatterjee D, et al. Transport properties of pancreatic cancer describe gemcitabine delivery and response. J Clin Invest. 2014;124:1525\u201336.","journal-title":"J Clin Invest"},{"key":"3650_CR5","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","volume":"163","author":"LD Wood","year":"2022","unstructured":"Wood LD, Canto MI, Jaffee EM, Simeone DM. Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment. Gastroenterology. 2022;163:386-402.e1.","journal-title":"Gastroenterology"},{"key":"3650_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","volume":"21","author":"ZI Hu","year":"2024","unstructured":"Hu ZI, O\u2019Reilly EM. Therapeutic developments in pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2024;21:7\u201324.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3650_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","volume":"19","author":"R Dhanasekaran","year":"2022","unstructured":"Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, Hansen AS, Gouw AM, Felsher DW. The MYC oncogene \u2014 the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol. 2022;19:23\u201336.","journal-title":"Nat Rev Clin Oncol"},{"key":"3650_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.semcancer.2020.11.008","volume":"83","author":"H Fatma","year":"2022","unstructured":"Fatma H, Maurya SK, Siddique HR. Epigenetic modifications of c-MYC: role in cancer cell reprogramming, progression and chemoresistance. Semin Cancer Biol. 2022;83:166\u201376.","journal-title":"Semin Cancer Biol"},{"key":"3650_CR9","doi-asserted-by":"publisher","first-page":"a014241\u2013a014241","DOI":"10.1101\/cshperspect.a014241","volume":"4","author":"M Gabay","year":"2014","unstructured":"Gabay M, Li Y, Felsher DW. Myc activation is a hallmark of cancer initiation and maintenance. Cold Spring Harb Perspect Med. 2014;4:a014241\u2013a014241.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3650_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang CV. Myc on the path to cancer. Cell. 2012;149:22\u201335.","journal-title":"Cell"},{"key":"3650_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nature07260","volume":"455","author":"L Soucek","year":"2008","unstructured":"Soucek L, Whitfield J, Martins CP, Finch AJ, Murphy DJ, Sodir NM, et al. Modelling myc inhibition as a cancer therapy. Nature. 2008;455:679\u201383.","journal-title":"Nature"},{"key":"3650_CR12","doi-asserted-by":"publisher","first-page":"eaar5012","DOI":"10.1126\/scitranslmed.aar5012","volume":"11","author":"M-E Beaulieu","year":"2019","unstructured":"Beaulieu M-E, Jauset T, Mass\u00f3-Vall\u00e9s D, Mart\u00ednez-Mart\u00edn S, Rahl P, Maltais L, et al. Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy. Sci Transl Med. 2019;11:eaar5012.","journal-title":"Sci Transl Med"},{"key":"3650_CR13","doi-asserted-by":"publisher","first-page":"e00248","DOI":"10.1128\/MCB.00248-19","volume":"39","author":"MJ Demma","year":"2019","unstructured":"Demma MJ, Mapelli C, Sun A, Bodea S, Ruprecht B, Javaid S, et al. Omomyc reveals new mechanisms to inhibit the MYC oncogene. Mol Cell Biol. 2019;39:e00248-19.","journal-title":"Mol Cell Biol"},{"key":"3650_CR14","doi-asserted-by":"publisher","first-page":"e2104344","DOI":"10.1002\/advs.202104344","volume":"9","author":"Y Xu","year":"2022","unstructured":"Xu Y, Yu Q, Wang P, Wu Z, Zhang L, Wu S, et al. A selective small-molecule c-Myc degrader potently regresses lethal c-Myc overexpressing tumors. Adv Sci. 2022;9:e2104344.","journal-title":"Adv Sci"},{"key":"3650_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41392-018-0008-7","volume":"3","author":"H Chen","year":"2018","unstructured":"Chen H, Liu H, Qing G. Targeting oncogenic Myc as a strategy for cancer treatment. Signal Transduct Target Ther. 2018;3:5.","journal-title":"Signal Transduct Target Ther"},{"key":"3650_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.ccr.2014.07.015","volume":"26","author":"WC Gustafson","year":"2014","unstructured":"Gustafson WC, Meyerowitz JG, Nekritz EA, Chen J, Benes C, Charron E, et al. Drugging MYCN through an allosteric transition in Aurora Kinase A. Cancer Cell. 2014;26:414\u201327.","journal-title":"Cancer Cell"},{"key":"3650_CR17","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1158\/2159-8290.CD-14-1040","volume":"5","author":"A Wiegering","year":"2015","unstructured":"Wiegering A, Uthe FW, Jamieson T, Ruoss Y, H\u00fcttenrauch M, K\u00fcspert M, et al. Targeting translation initiation bypasses signaling crosstalk mechanisms that maintain high MYC levels in colorectal cancer. Cancer Discov. 2015;5:768\u201381.","journal-title":"Cancer Discov"},{"key":"3650_CR18","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.3390\/ijms20225573","volume":"20","author":"X Zhang","year":"2019","unstructured":"Zhang X, Wang W, Zhu W, Dong J, Cheng Y, Yin Z, et al. Mechanisms and functions of long non-coding RNAs at multiple regulatory levels. Int J Mol Sci. 2019;20:5573.","journal-title":"Int J Mol Sci"},{"key":"3650_CR19","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1038\/s41418-023-01225-x","volume":"30","author":"G Wu","year":"2023","unstructured":"Wu G, Su J, Zeng L, Deng S, Huang X, Ye Y, et al. LncRNA BCAN-AS1 stabilizes c-Myc via N6-methyladenosine-mediated binding with SNIP1 to promote pancreatic cancer. Cell Death Differ. 2023;30:2213\u201330.","journal-title":"Cell Death Differ"},{"key":"3650_CR20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13045-021-01123-0","volume":"14","author":"X Qian","year":"2021","unstructured":"Qian X, Yang J, Qiu Q, Li X, Jiang C, Li J, et al. LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC. J Hematol OncolJ Hematol Oncol. 2021;14:112.","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"3650_CR21","doi-asserted-by":"publisher","first-page":"e703","DOI":"10.1002\/ctm2.703","volume":"12","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Zhou B, Hu X, Ying S, Zhou Q, Xu W, et al. LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability. Clin Transl Med. 2022;12:e703.","journal-title":"Clin Transl Med"},{"key":"3650_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13045-022-01272-w","volume":"15","author":"Y Liu","year":"2022","unstructured":"Liu Y, Shi M, He X, Cao Y, Liu P, Li F, et al. Lncrna-pacerr induces pro-tumour macrophages via interacting with miR-671-3p and m6a-reader IGF2BP2 in pancreatic ductal adenocarcinoma. J Hematol Oncol. 2022;15:52.","journal-title":"J Hematol Oncol"},{"key":"3650_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3892\/ijo.2021.5299","volume":"60","author":"H Huang","year":"2021","unstructured":"Huang H, Li H, Pan R, Wang S, Khan A, Zhao Y, et al. Ribosome 18S m6 A methyltransferase METTL5 promotes pancreatic cancer progression by modulating c-Myc translation. Int J Oncol. 2021;60:9.","journal-title":"Int J Oncol"},{"key":"3650_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20:285\u201395.","journal-title":"Nat Cell Biol"},{"key":"3650_CR25","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.7150\/ijbs.58886","volume":"17","author":"X Zhao","year":"2021","unstructured":"Zhao X, Li H, Lyu S, Zhai J, Ji Z, Zhang Z, et al. Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma. Int J Biol Sci. 2021;17:2590\u2013605.","journal-title":"Int J Biol Sci"},{"issue":"11","key":"3650_CR26","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s43018-020-00121-4","volume":"1","author":"NG Steele","year":"2020","unstructured":"Steele NG, Carpenter ES, Kemp SB, Sirihorachai VR, The S, Delrosario L, et al. Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer. Nat Cancer. 2020;1(11):1097\u2013112.","journal-title":"Nat Cancer"},{"key":"3650_CR27","first-page":"169","volume":"26","author":"T-P Xu","year":"2023","unstructured":"Xu T-P, Yu T, Xie M-Y, Fang Y, Xu T-T, Pan Y-T, et al. LOC101929709 promotes gastric cancer progression by aiding LIN28B to stabilize c-MYC mRNA. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc. 2023;26:169\u201386.","journal-title":"Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc"},{"key":"3650_CR28","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1089\/ars.2019.7826","volume":"31","author":"S Manohar","year":"2019","unstructured":"Manohar S, Jacob S, Wang J, Wiechecki KA, Koh HWL, Sim\u00f5es V, et al. Polyubiquitin chains linked by lysine residue 48 (K48) selectively target oxidized proteins in vivo. Antioxid Redox Signal. 2019;31:1133\u201349.","journal-title":"Antioxid Redox Signal"},{"key":"3650_CR29","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12964-023-01360-5","volume":"21","author":"Q Jin","year":"2023","unstructured":"Jin Q, Qu H, Quan C. New insights into the regulation of METTL3 and its role in tumors. Cell Commun Signal. 2023;21:334.","journal-title":"Cell Commun Signal"},{"key":"3650_CR30","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s13238-018-0518-7","volume":"10","author":"J Huang","year":"2019","unstructured":"Huang J, Dong X, Gong Z, Qin L-Y, Yang S, Zhu Y-L, et al. Solution structure of the RNA recognition domain of METTL3-METTL14 N6-methyladenosine methyltransferase. Protein Cell. 2019;10:272\u201384.","journal-title":"Protein Cell"},{"key":"3650_CR31","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1261\/rna.065649.118","volume":"24","author":"M Jia","year":"2018","unstructured":"Jia M, Gut H, Chao JA. Structural basis of IMP3 RRM12 recognition of RNA. RNA N Y N. 2018;24:1659\u201366.","journal-title":"RNA N Y N"},{"key":"3650_CR32","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12943-022-01608-7","volume":"21","author":"B Yao","year":"2022","unstructured":"Yao B, Zhang Q, Yang Z, An F, Nie H, Wang H, et al. CircEZH2\/miR-133b\/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m6A-modified CREB1 mRNA. Mol Cancer. 2022;21:140.","journal-title":"Mol Cancer"},{"key":"3650_CR33","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","volume":"40","author":"H Weng","year":"2022","unstructured":"Weng H, Huang F, Yu Z, Chen Z, Prince E, Kang Y, et al. The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. Cancer Cell. 2022;40:1566-1582.e10.","journal-title":"Cancer Cell"},{"key":"3650_CR34","doi-asserted-by":"crossref","unstructured":"Duffy MJ, O\u2019Grady S, Tang M, Crown J. MYC as a target for cancer treatment. Cancer Treat Rev. 2021;94:102154.","DOI":"10.1016\/j.ctrv.2021.102154"},{"key":"3650_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/15384047.2021.2017223","volume":"23","author":"M Ala","year":"2022","unstructured":"Ala M. Target c-Myc to treat pancreatic cancer. Cancer Biol Ther. 2022;23:34\u201350.","journal-title":"Cancer Biol Ther"},{"key":"3650_CR36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1158\/0008-5472.CAN-14-3607","volume":"76","author":"Y Li","year":"2016","unstructured":"Li Y, Wang Z, Shi H, Li H, Li L, Fang R, et al. HBXIP and LSD1 scaffolded by lncRNA Hotair mediate transcriptional activation by c-Myc. Cancer Res. 2016;76:293\u2013304.","journal-title":"Cancer Res"},{"key":"3650_CR37","doi-asserted-by":"publisher","first-page":"18697","DOI":"10.1073\/pnas.1415669112","volume":"111","author":"C-L Hung","year":"2014","unstructured":"Hung C-L, Wang L-Y, Yu Y-L, Chen H-W, Srivastava S, Petrovics G, et al. A long noncoding RNA connects c-Myc to tumor metabolism. Proc Natl Acad Sci U S A. 2014;111:18697\u2013702.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3650_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.3192","volume":"47","author":"MK Iyer","year":"2015","unstructured":"Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, et al. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet. 2015;47:199\u2013208.","journal-title":"Nat Genet"},{"key":"3650_CR39","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/s41374-022-00736-4","volume":"102","author":"Z Xing","year":"2022","unstructured":"Xing Z, Li S, Xing J, Yu G, Wang G, Liu Z. Silencing of LINC01963 enhances the chemosensitivity of prostate cancer cells to docetaxel by targeting the miR-216b-5p\/TrkB axis. Lab Investig J Tech Methods Pathol. 2022;102:602\u201312.","journal-title":"Lab Investig J Tech Methods Pathol"},{"key":"3650_CR40","doi-asserted-by":"publisher","first-page":"4661929","DOI":"10.1155\/2022\/4661929","volume":"2022","author":"W Jiang","year":"2022","unstructured":"Jiang W, Du Y, Zhang W, Zhou W. Construction of a prognostic model based on cuproptosis-related lncRNA signatures in pancreatic cancer. Can J Gastroenterol Hepatol. 2022;2022:4661929.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"3650_CR41","doi-asserted-by":"publisher","first-page":"113339","DOI":"10.1016\/j.yexcr.2022.113339","volume":"420","author":"C Hou","year":"2022","unstructured":"Hou C, Ye Z, Yang S, Jiang Z, Wang J, Wang E. Lysine demethylase 1B (Kdm1b) enhances somatic reprogramming through inducing pluripotent gene expression and promoting cell proliferation. Exp Cell Res. 2022;420:113339.","journal-title":"Exp Cell Res"},{"key":"3650_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.molcel.2015.01.038","volume":"58","author":"Y Yang","year":"2015","unstructured":"Yang Y, Yin X, Yang H, Xu Y. Histone demethylase LSD2 acts as an E3 ubiquitin ligase and inhibits cancer cell growth through promoting proteasomal degradation of OGT. Mol Cell. 2015;58:47\u201359.","journal-title":"Mol Cell"},{"key":"3650_CR43","doi-asserted-by":"publisher","unstructured":"Kim H-M, Liu Z, Kim H-M, Liu Z. LSD2 is an epigenetic player in multiple types of cancer and beyond. Biomolecules. 2024;14. https:\/\/doi.org\/10.3390\/biom14050553.","DOI":"10.3390\/biom14050553"},{"key":"3650_CR44","doi-asserted-by":"publisher","first-page":"107286","DOI":"10.1016\/j.nlm.2020.107286","volume":"174","author":"M Musaus","year":"2020","unstructured":"Musaus M, Navabpour S, Jarome TJ. The diversity of linkage-specific polyubiquitin chains and their role in synaptic plasticity and memory formation. Neurobiol Learn Mem. 2020;174:107286.","journal-title":"Neurobiol Learn Mem"},{"issue":"3","key":"3650_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1042\/BST20253015","volume":"53","author":"MR McFarland","year":"2025","unstructured":"McFarland MR, Kulathu Y. Emerging tools and methods to study cell signalling mediated by branched ubiquitin chains. Biochem Soc Trans. 2025;53(3):BST20253015.","journal-title":"Biochem Soc Trans"},{"key":"3650_CR46","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ncb3358","volume":"18","author":"R Yau","year":"2016","unstructured":"Yau R, Rape M. The increasing complexity of the ubiquitin code. Nat Cell Biol. 2016;18:579\u201386.","journal-title":"Nat Cell Biol"},{"key":"3650_CR47","doi-asserted-by":"publisher","first-page":"100175","DOI":"10.1016\/j.mcpro.2021.100175","volume":"21","author":"M Villamil","year":"2022","unstructured":"Villamil M, Xiao W, Yu C, Huang L, Xu P, Kaiser P. The Ubiquitin Interacting Motif-Like Domain of Met4 Selectively Binds K48 Polyubiquitin Chains. Mol Cell Proteomics. 2022;21:100175.","journal-title":"Mol Cell Proteomics"},{"key":"3650_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11658-020-00245-6","volume":"26","author":"M Tracz","year":"2021","unstructured":"Tracz M, Bialek W. Beyond K48 and K63: non-canonical protein ubiquitination. Cell Mol Biol Lett. 2021;26:1.","journal-title":"Cell Mol Biol Lett"},{"key":"3650_CR49","doi-asserted-by":"publisher","unstructured":"Waltho A, Popp O, Lenz C, Pluska L, Lambert M, D\u00f6tsch V, et al. K48- and K63-linked ubiquitin chain interactome reveals branch- and length-specific ubiquitin interactors. Life Sci Alliance. 2024;7. https:\/\/doi.org\/10.26508\/lsa.202402740.","DOI":"10.26508\/lsa.202402740"},{"key":"3650_CR50","first-page":"e2307639","volume":"11","author":"T Jin","year":"2024","unstructured":"Jin T, Yang L, Chang C, Luo H, Wang R, Gan Y, et al. HnRNPA2B1 ISGylation regulates m6A-tagged mRNA selective export via ALYREF\/NXF1 complex to foster breast cancer development. Adv Sci Weinh Baden-Wurtt Ger. 2024;11:e2307639.","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"3650_CR51","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41419-024-06664-z","volume":"15","author":"R Li","year":"2024","unstructured":"Li R, Zhu C, Wang Y, Wang X, Wang Y, Wang J, et al. The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system. Cell Death Dis. 2024;15:275.","journal-title":"Cell Death Dis"},{"key":"3650_CR52","doi-asserted-by":"publisher","first-page":"217085","DOI":"10.1016\/j.canlet.2024.217085","volume":"598","author":"X-J Luo","year":"2024","unstructured":"Luo X-J, Lu Y-X, Wang Y, Huang R, Liu J, Jin Y, et al. M6A-modified lncRNA FAM83H-AS1 promotes colorectal cancer progression through PTBP1. Cancer Lett. 2024;598:217085.","journal-title":"Cancer Lett"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-026-03650-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03650-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03650-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:04:22Z","timestamp":1781651062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-026-03650-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3650"],"URL":"https:\/\/doi.org\/10.1186\/s13046-026-03650-5","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Institutional Animal Care Use and Welfare Committee at the Center for Experimental Animal Research of the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (IACUC-A02-2023\u2013059). Animals were handled in accordance with institutional guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}